Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Invest Dermatol. 2012 Jan 26;132(4):1188–1195. doi: 10.1038/jid.2011.447

Figure 3. Defects in Involucrin and E-cadherin synthesis and Processing Are Normalized by Inhibiting SGPL1.

Figure 3

Human Keratinocytes were cultured and treated as in Figure 2, above. Cells were harvested 48 hours after raising extracellular Ca2+. E-cadherin and involucrin protein levels were assessed using Western blotting (see Methods).